Genomadix

Genomadix on path to profitability, biotech firm’s CEO says

‘Significant milestone’: FDA approves Genomadix’s rapid genetic-testing device for sale in U.S.

Techopia

The company’s flagship product, dubbed the Genomadix Cube, is a coffee cup-sized lab-in-a-box that is engineered to extract, amplify and identify genetic material in about

Ottawa startups remain bullish on fundraising despite headwinds in VC market

Techopia

While venture capital investment in Canadian firms plummeted in 2022 as tech valuations took a widespread hit and economic headwinds mounted, some Ottawa tech companies

Mayo Clinic acquires equity stake in rapid COVID test-maker Genomadix

Techopia

Ottawa startup awaiting regulatory approval for portable device says partnership with world-renowned U.S. research facility will help further develop its technology.

Rising from Spartan’s ashes: Genomadix says retooled rapid COVID test ready for market

Techopia

Ottawa biotech startup has raised $7.5 million in fresh funding as it looks to capitalize what it says is the continued need for “a decentralized,

Q&A: New CEO has high hopes for Spartan Cube after family trust buys biotech firm’s COVID-testing IP

Techopia

Spartan filed for creditor protection and laid off two-thirds of its 90 employees after facing continued questions about the reliability of its COVID-detecting lab-in-a-box.